sulfamethoxazole has been researched along with Kidney, Polycystic in 2 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study examines the causes for the therapeutic failure of trimethoprim-sulfamethoxazole in a patient with infected cysts caused by a sensitive strain of Escherichia coli." | 7.67 | Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease. ( Schwab, SJ; Weaver, ME, 1986) |
| "This study examines the causes for the therapeutic failure of trimethoprim-sulfamethoxazole in a patient with infected cysts caused by a sensitive strain of Escherichia coli." | 3.67 | Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease. ( Schwab, SJ; Weaver, ME, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elzinga, LW | 1 |
| Golper, TA | 1 |
| Rashad, AL | 1 |
| Carr, ME | 1 |
| Bennett, WM | 1 |
| Schwab, SJ | 1 |
| Weaver, ME | 1 |
2 other studies available for sulfamethoxazole and Kidney, Polycystic
| Article | Year |
|---|---|
Trimethoprim-sulfamethoxazole in cyst fluid from autosomal dominant polycystic kidneys.
Topics: Adult; Anti-Infective Agents, Urinary; Biological Availability; Enterococcus faecalis; Escherichia c | 1987 |
Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease.
Topics: Cysts; Drug Combinations; Drug Evaluation; Drug Synergism; Escherichia coli; Escherichia coli Infect | 1986 |